James Yi Li is patent litigator proficient in a diverse range of technologies. He is an integral part of trial teams for life sciences patent litigation under the Hatch-Waxman Act and the Biologics Price Competition and Innovation Act, including matters involving chemistry, pharmaceuticals, and biotechnology. James also has experience litigating software and consumer electronics patents in both district court and inter partes review.
James received his law degree from Harvard Law School, cum laude, in 2015. He graduated from the University of Michigan with a B.S.E. in Biomedical Engineering, summa cum laude, and a Master of Engineering in Pharmaceutical Engineering.
- Represented international pharmaceutical company against multiple generic challengers on patents related to treatment of chemotherapy induced nausea
- Represented international pharmaceutical company against multiple generic challengers on patents related to treatment of multiple myeloma
- Represented international pharmaceutical company against multiple generic challengers on patents related to treatment of heart failure
- Represented international pharmaceutical company against multiple generic challengers on patents related to treatment of irritable bowel syndrome
- Represented international pharmaceutical company against generic challenger on patent related to treatment of hypotrichosis
- Represented international pharmaceutical company on patents related to treatment of HIV
- Represented international pharmaceutical company on patents related to treatment of ovarian cancer
- Represented international pharmaceutical company on patents related to treatment of acute myeloid leukemia
- Represented leading biologics company in BPCIA litigation relating to a biosimilar version of Humira®
- Represented leading biologics company in BPCIA litigation relating to a biosimilar version of Avastin®
- Represented biotechnology company on patents relating to blood glucose monitors
- Represented international consumer electronics company on patents relating to TV
- Represented international consumer electronics company on patents relating to smartphones
Admissions
Bar Admissions
- New York
Registered to Practice
- US Patent & Trademark Office
Education
- Harvard Law School, J.D., cum laude
- University of Michigan, M.Eng., Pharmaceutical Engineering
- University of Michigan, B.S.E., Biomedical Engineering, summa cum laude
Honors & Awards
- Named a “Rising Star” by LMG Life Sciences (2023)
Professional Activities
Publications
- Co-Author, “AI and Life Sciences Patents: Separating Myth From Reality,” New York Law Journal (March 20, 2020)
- Co-Author (Yu J, Yu J, Mani RS, et al.), “An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression,” Cancer Cell. 2010, 17(5):443-454.
Speaker
- “Paragraph IV Patent Protection and Litigation: Addressing the Complex Challenges,” The Knowledge Group (October 3, 2019)
Related Practices
Related Industries